Imaging

Dental imaging firm Calcivis expands into U.S.

By DrBicuspid.com staff writers

March 13, 2023 -- Scotland-based dental imaging technology company Calcivis plans to bring its tooth decay imaging device to the U.S. market.

In March 2020, Calcivis received premarket approval from the U.S. Food and Drug Administration to test its system that visualizes enamel demineralization and can help identify carious lesions. The imaging system applies a patented photoprotein that in the presence of free calcium ions released from an actively decaying tooth surface produces a very short, low-level light flash. An integrated intraoral sensor within the device detects the light flash and presents clinicians with a chairside demineralization map.

Calcivis gets FDA approval to test imaging system
Calcivis, a medical device company focused on managing tooth decay, has received premarket approval from the U.S. Food and Drug Administration (FDA) to...
Calcivis completes 1st clinical study of new caries imaging system
Calcivis, a medical devices company that is focused on managing tooth decay, announced that it has completed a first clinical study of its Calcivis caries...
Company gets funding to help develop caries imaging system
Calcivis has received a Biomedical Catalyst award and also raised 800,000 pounds ($1.11 million) in equity funding. The new funding will support further...

Copyright © 2023 DrBicuspid.com

Last Updated ka 3/13/2023 11:31:33 AM